Entering text into the input field will update the search result below

West Pharma cut to Neutral at BofA citing near-term headwinds after Q3 update

Wall Street New York City

aluxum/E+ via Getty Images

Bank of America downgraded West Pharmaceutical Services (NYSE:WST) to Neutral from Buy on Friday, citing supply-side headwinds and pressure on COVID-19-related sales after the life sciences company reported its Q3 2022 results.

West Pharma (

Recommended For You

About WST Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
WST--
West Pharmaceutical Services, Inc.